Study involved over 1 lakh women who were randomly assigned to either AI-supported breast cancer screening or standard screening without AI & followed up over 2 yrs. Median age was 54.
US researchers conducted a trial of over 28,000 women aged 40-74 to find an effective way of distributing breast cancer screening resources. Results published in JAMA on 12 Dec.
Median & mean out-of-pocket expenditure are Rs 1,26,988 and Rs 1,86,461, respectively, find researchers at Tata Memorial Centre & International Institute for Population Sciences.
The study, published in American Cancer Society Journal, shows survival rate 5 yrs after diagnosis ranges from 41.9% in Pasighat to 74.9% in Mizoram. In countries like US, it's over 90%.
Breast cancer is one of the most commonly diagnosed cancers in India. Most existing Trastuzumab brands in Indian market are priced between Rs 40,000 and Rs 54,000 per 440 mg vial.
Researchers have found that women who have children are at a higher risk of developing a heart disease, strokes and heart failure. But there is an upside.
Here’s what’s happening across the border: IMF and World Bank have some crucial suggestions for Pakistan to alter economic landscape; President’s house lit up pink to promote breast cancer awareness.
While the Russia-Ukraine war saw the BJP projecting PM Modi as a ‘vishwaguru’ who could end international conflicts, the party has made a nuanced shift in its electoral strategy vis-à-vis the West Asia war.
Report on impact of AI emergence—drawing upon depositions from several ministries—confirms that the developments come in the absence of AI laws or considerations over them.
It’s easy to understand why the government can’t speak the hard truth. When this war ends, as all wars do, India’s interests will lie with both the winner and the loser.
COMMENTS